Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT

2013 ◽  
Vol 54 (8) ◽  
pp. 837-842 ◽  
Author(s):  
Sabine Schmidt ◽  
Vincent Dunet ◽  
Melanie Koehli ◽  
Michael Montemurro ◽  
Reto Meuli ◽  
...  
Mastology ◽  
2019 ◽  
Vol 29 (3) ◽  
pp. 155-157
Author(s):  
Almir Galvão Vieira Bitencourt ◽  
◽  
Luciana Graziano ◽  
Carla Tajima ◽  
Fabiana Baroni Makdissi ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Jonas Gabriel William Fischer ◽  
Claudia Irene Maushart ◽  
Anton S. Becker ◽  
Julian Müller ◽  
Philipp Madoerin ◽  
...  

2015 ◽  
Vol 133 (2) ◽  
pp. 141-150 ◽  
Author(s):  
Rodrigo Regacini ◽  
Andrea Puchnick ◽  
David Carlos Shigueoka ◽  
Wagner Iared ◽  
Henrique Manoel Lederman

CONTEXT AND OBJECTIVE: Positron emission tomography with [18]F-fluoro-2-deoxyglucose (FDG-PET/CT) has been advocated as the method of choice for lymphoma staging, since it enables whole-body analysis with high sensitivity for detection of affected areas and because it combines capacities for anatomical and functional assessment. With technological advances, magnetic resonance imaging (MRI) has emerged as an alternative to FDG-PET/CT. This systematic review with meta-analysis aimed to compare whole-body diffusion-weighted MRI (WB-MRI) with FDG-PET/CT for lymphoma staging. DESIGN AND SETTING: Systematic review on diagnostic test accuracy studies conducted at a public university. METHODS: The Medline, Scopus, Embase and Lilacs databases were searched for studies published up to September 2013 that compared WB-MRI and FDG-PET/CT for lymphoma staging. The reference lists of included studies were checked for any relevant additional citations. RESULTS: Six studies that evaluated the initial lymphoma staging in 116 patients were included. WB-MRI and FDG-PET/CT agreed in 90.5% of the cases (κ = 0.871; P < 0.0001). In most of the studies, when there was disagreement between the methods, WB-MRI overstaged in relation to FDG-PET/CT. The sensitivity of WB-MRI and FDG-PET/CT, in comparison with the clinical-radiological standard, ranged from 59 to 100% and from 63 to 100% respectively. CONCLUSION: WB-MRI is a highly sensitive method for initial lymphoma staging. It has excellent agreement with FDG-PET/CT and is a great alternative for managing lymphoma patients, without using ionizing radiation or an intravenous contrast agent.


2017 ◽  
Vol 48 (4) ◽  
pp. 1043-1047 ◽  
Author(s):  
Domenico Albano ◽  
Francesco Agnello ◽  
Caterina Patti ◽  
Ludovico La Grutta ◽  
Alberto Bruno ◽  
...  

Author(s):  
Boby Varkey Maramattom ◽  
Shagos Gopalan Nair Santhamma

Neurotuberculosis (NT) continues to be a global health problem with severe morbidity and mortality. The manifestations of NT are well-known and encompass forms such as meningitis, tuberculomas, military tuberculosis, ventriculitis, and brain abscess. Data of all patients with central nervous system tuberculosis who underwent magnetic resonance imaging (MRI) and/or 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography–computed tomography (PET-CT) were analyzed. Over a 7-year period (2014–2021), we encountered three patients who had dense neurological deficits and 18F-FDG PET-CT results suggesting focal cortical encephalitis. 18F-FDG PET-CT demonstrated focal hypermetabolism involving focal–regional areas of the left hemisphere that corresponded to clinical deficits in two of the three patients. Follow-up 18F-FDG PET-CT showed improvement in cortical hypermetabolism in all three patients that corresponded with clinical improvement. MRI of the brain with contrast showed subtle leptomeningeal enhancement in these areas, along with other features of NT, but it could not detect cortical involvement. A literature review also revealed some previous descriptions that seemed to be consistent with tuberculous encephalitis (TbE). TbE seems to be a distinct subset of NT and may coexist with other features of NT or disseminated tuberculosis. It may be detected by 18F-FDG PET-CT even when brain MRI does not show any evident abnormality to explain a focal neurological deficit. 18F-FDG PET-CT can be considered during the evaluation and monitoring of NT to detect TbE. The presence of TbE may affect the prognosis and treatment duration of NT.


Sign in / Sign up

Export Citation Format

Share Document